Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 4/20 | 0.50 |
| ▸ | THRB | P10828 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.45 |
| ▸ | DNM1 | Q05193 | 7/20 | 0.38 |
| ▸ | LMNA | P02545 | 2/20 | 0.38 |
| ▸ | MEN1 | O00255 | 2/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.38 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6249171 | 1.00 | TSHR (0.50) | TSHRTHRBALDH1A1DNM1LMNA | |
| SCHEMBL31286348 | 1.00 | TSHR (0.50) | TSHRTHRBALDH1A1DNM1LMNA | |
| SCHEMBL9453441 | 1.00 | TSHR (0.50) | TSHRTHRBALDH1A1DNM1LMNA | |
| SCHEMBL8160689 | 1.00 | TSHR (0.50) | TSHRTHRBALDH1A1DNM1LMNA | |
| SCHEMBL18108232 | 1.00 | TSHR (0.50) | TSHRTHRBALDH1A1DNM1LMNA | |
| SCHEMBL10894089 | 1.00 | TSHR (0.50) | TSHRTHRBALDH1A1DNM1LMNA | |
| SCHEMBL17966475 | 1.00 | TSHR (0.50) | TSHRTHRBALDH1A1DNM1LMNA | |
| SCHEMBL131777 | 1.00 | TSHR (0.50) | TSHRTHRBALDH1A1DNM1LMNA | |
| SCHEMBL21817839 | 1.00 | TSHR (0.50) | TSHRTHRBALDH1A1DNM1LMNA | |
| SCHEMBL25338689 | 0.97 | TSHR (0.47) | TSHRTHRBALDH1A1DNM1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 816 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4028379-B1 | IMPROVED METHOD FOR THE PREPARATION OF CYCLOPROYL COMPOUNDS FROM ALKENES | SALTIGO GMBH (DE) | 2025-11-19 | — | — | EP | claimed |
| CN-119059879-A | Cyclopropanation of substituted olefins | 国际香料和香精公司 | 2024-12-03 | — | — | CN | claimed |
| WO-2024232632-A1 | TRANSITION METAL SUPPORTED CATALYST WITH IMPROVED HYDROGENATION ACTIVITY AND USE THEREOF | 한양대학교 산학협력단 | 2024-11-14 | — | — | WO | claimed |
| US-20240352315-A1 | METHODS AND COMPOSITIONS FOR ENHANCED DISPERSION OF PHOSPHOR IN A POLYMERIC MATRIX | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM | 2024-10-24 | — | — | US | claimed |
| CN-117982404-A | Ocular surface slow release drug delivery implant capable of adjusting drug release rate and preparation method thereof | 复旦大学附属眼耳鼻喉科医院 | 2024-05-07 | — | — | CN | claimed |
| US-20240010511-A1 | METHODS AND COMPOSITIONS FOR SYNTHESIS OF PHOSPHOR AND ITS INCORPORATION IN A POLYMER MATRIX FOR LIGHT CONVERSION | SOLGRO, INC. (US) | 2024-01-11 | — | — | US | claimed |
| US-20220348526-A1 | Improved process for preparing cyclopropyl compounds from alkenes | SALTIGO GMBH (DE) | 2022-11-03 | — | — | US | claimed |
| EP-4028379-A1 | IMPROVED PROCESS FOR PREPARING CYCLOPROPYL COMPOUNDS FROM ALKENES | Saltigo GmbH (DE) | 2022-07-20 | — | — | EP | claimed |
| CN-114401938-A | Improved process for the preparation of cyclopropyl compounds from olefins | 赛拓有限责任公司 | 2022-04-26 | — | — | CN | claimed |
| CN-113502102-A | Heat-insulating coating and preparation method thereof | 贵州广毅节能环保科技有限公司 | 2021-10-15 | — | — | CN | claimed |
| JP-4796259-B2 | — | — | 2011-10-19 | — | — | JP | claimed |
| US-20110124001-A1 | Compositions For Use In Detection Of Multiple Analytes | SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS GMBH (DE) | 2011-05-26 | — | — | US | claimed |
| EP-1979019-A2 | BIOACTIVE MATERIAL DELIVERY SYSTEMS COMPRISING SOL-GEL COMPOSITIONS | Medlogics Device Corporation (US) | 2008-10-15 | — | — | EP | claimed |
| WO-2007092043-A2 | BIOACTIVE MATERIAL DELIVERY SYSTEMS COMPRISING SOL-GEL COMPOSITIONS | MEDLOGICS DEVICE CORPORATION (US) | 2007-08-16 | — | — | WO | claimed |
| US-20070071789-A1 | Bioactive Material Delivery Systems Comprising Sol-Gel Compositions | MEDLOGICS DEVICE CORPORATION (US) | 2007-03-29 | — | — | US | claimed |
| EP-1305632-A2 | COMPOSITIONS FOR DETECTION OF MULTIPLE ANALYTES | Dade Behring Marburg GmbH (DE) | 2003-05-02 | — | — | EP | claimed |
| EP-0759439-B1 | Synthesis of silylated cyanohydrins | CREANOVA INC (US) | 2002-09-18 | — | — | EP | claimed |
| WO-2001084157-A2 | COMPOSITIONS FOR DETECTION OF MULTIPLE ANALYTES | DADE BEHRING MARBURG GMBH (DE) | 2001-11-08 | — | — | WO | claimed |
| EP-0759439-A2 | Synthesis of silylated cyanohydrins | HÜLS AMERICA INC. (US) | 1997-02-26 | — | — | EP | claimed |
| US-5594156-A | REACTING AN ALDEHYDE OR KETONE WITH HYDROGEN CYANIDE, A TRISUBSTITUTED HALOSILANE AND A CORRESPONDINGLY SUBSTITUTED DISILAZANE OR SILYL AMINE | HULS AMERICA INC. (US) | 1997-01-14 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110124001-A1 | Compositions For Use In Detection Of Multiple Analytes | CYBB, CD14, MPO | TSHR 3628/4885THRB 3907/4885ALDH1A1 950/4885 |
| US-20220348526-A1 | Improved process for preparing cyclopropyl compounds from alkenes | CYP4F3, CXXC4, ZRANB2 | TSHR 3420/4885THRB 4657/4885ALDH1A1 642/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.